Current Advances in the Management of Nonurothelial Subtypes of Bladder Cancer
Urothelial cancer (UC) is the most common histology seen in bladder tumors. The 2022
WHO classification of urinary tract tumors includes a list of less common subtypes (formerly …
WHO classification of urinary tract tumors includes a list of less common subtypes (formerly …
[HTML][HTML] Evolving Treatment Landscape of Frontline Therapy for Metastatic Urothelial Carcinoma: Current Insights and Future Perspectives
Cisplatin-based chemotherapy has long been the standard first-line (1L) treatment for
metastatic urothelial carcinoma (mUC). However, up to 50% of patients with mUC may be …
metastatic urothelial carcinoma (mUC). However, up to 50% of patients with mUC may be …
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract
MJ Moussa, GC Tabet, AO Siefker‐Radtke… - Cancer …, 2025 - Wiley Online Library
Introduction Small cell neuroendocrine carcinoma of the urinary tract (SCNEC‐URO) has an
inferior prognosis compared to conventional urothelial carcinoma (UC). Here, we evaluate …
inferior prognosis compared to conventional urothelial carcinoma (UC). Here, we evaluate …
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy
MJ Moussa, J Khandelwal, NR Wilson, SA Naik… - Current …, 2024 - mdpi.com
Small cell bladder cancer (SCBC) is a rare and aggressive disease, often treated with
platinum/etoposide-based chemotherapy. Key molecular drivers include the inactivation of …
platinum/etoposide-based chemotherapy. Key molecular drivers include the inactivation of …